2013
DOI: 10.1136/bcr-2013-008762
|View full text |Cite
|
Sign up to set email alerts
|

Recurrent atypical fibroxanthoma of the limbus

Abstract: We report an unusual presentation of recurrent atypical fibroxanthoma of the limbus. Clinical and histological appearances, as well as management are discussed and the current literature is reviewed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
12
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 11 publications
0
12
0
1
Order By: Relevance
“…6 The sole case of AFX reported in the palpebral conjunctiva was in a 94-yearold woman. 8 Previous conjunctival AFX cases have been either spindle-cell predominant 7,9 or more pleomorphic with numerous histocyte-like (epithelioid) cells and multinucleated giant cells, as in our patient. 6,8 Treatment of conjunctival AFX relies on complete excision, 7 similar to therapy for skin AFX.…”
Section: Pathologymentioning
confidence: 73%
See 3 more Smart Citations
“…6 The sole case of AFX reported in the palpebral conjunctiva was in a 94-yearold woman. 8 Previous conjunctival AFX cases have been either spindle-cell predominant 7,9 or more pleomorphic with numerous histocyte-like (epithelioid) cells and multinucleated giant cells, as in our patient. 6,8 Treatment of conjunctival AFX relies on complete excision, 7 similar to therapy for skin AFX.…”
Section: Pathologymentioning
confidence: 73%
“…1 Incomplete excision may result in local tumor recurrence. 1,7 Too few cases of conjunctival AFX have been reported to know whether there is any metastatic potential, but this seems extremely unlikely based on the biological behavior of skin AFX.…”
Section: Pathologymentioning
confidence: 96%
See 2 more Smart Citations
“…Data on recurrence in ocular lesions is limited, however. There are a few case reports of recurrent atypical fibroxanthoma of the eyelid and limbus [14,15]. Follow-up is recommended annually for monitoring of recurrence.…”
Section: Discussionmentioning
confidence: 99%